Five of Kirin’s Lactococcus lactis strain Plasma products registered as “foods with function claims”

Kirin has announced five of its products – three soft drinks and two supplements – that utilise Lactococcus lactis strain Plasma have been registered as foods with function claims with Japan’s Consumer Affairs Agency (CAA). According to Kirin, this marks the first immune system-related product to be registered in Japan. This further pave way for the labelling of function claims on products, providing enhanced reliability and reassurance for consumers when making purchasing decisions.

The Lactococcus lactis strain Plasma is a product of joint research by Kirin, Koiwai Dairy Products, and Kyowa Hakko Bio. It is a type of strain of Lactococcus lactis, which is a natural lactic acid bacterium used for the fermentation of cheese and yoghurt. The company claimed that the inclusion of Lactococcus lactis strain Plasma in the product shows to support maintenance of the immune system in healthy individuals by stimulating plasmacytoid dendritic cells (pDC).

The Kirin Group Vision 2027 sets out the broad goal of creating value across the world of food and beverages to pharmaceuticals. To augment the company’s existing food and beverages and pharmaceuticals domains, it has launched a new health science domain to support consumers stay fit and healthy by leveraging advanced fermentation and biotechnology it has amassed over the years. The development of Lactococcus lactis strain Plasma is one such example.

Moving forward, Kirin is confident in accelerating domestic sales as well as expand overseas sales of products that utilise Lactococcus lactis strain Plasma, leading to further contribution to the health and well-being of the global community.